Program 2018-02-19T15:15:29+00:00

Scientific Program


 Day 1: Tuesday – June 26, 2018
09:00 – 18:00 WMDA Working Group Meetings
Day 2: Wednesday – June 27, 2018
08:00 – 18:00 WMDA Working Group Meetings
Day 3: Thursday – June 28, 2018
08:30 – 12:30 ZKRD Annual Conference (in German)
Talks and discussions on current developments in the daily business of the ZKRD and its national cooperation partners
13:30 – 14:00 Opening Session
14:00 – 15:00 Key Note Lecture
15:30 – 17:00 Ethical Challenges
Are Ethical Principles Global ?
Patient Welfare or Donor Safety?
Rudolf Schwabe (Bern, Switzerland)
The Principle of the Prohibition of Financial Gain
Day 4: Friday – June 29, 2018
09:00 – 10:30 Current Perspectives in Donor Selection
HLA 20/20: Current Evidence and Where It Ends
Effie Petersdorf (Seattle, United States)
The Role of KIR in Donor Selection
Katharine Hsu (New York, United States)
Clinical Pathways for the Selection Donor and Stem Cell Source
Nicolaus Kröger (Hamburg, Germany)
Panel Discussion
11:00 – 12:30 International Search Systems
Google’s Perspective on Searching
Joao Rufino (London, United Kingdom)
The Future of International Search Systems
1. The Clinical Perspective
Jeff Szer (Melbourne, Australia)
2. The Registry Perspective
Betina Sørensen (Aarhus, Denmark)
3. The Technological Perspective
Matt Prestegaard (Minneapolis, United States)
Panel Discussion
14:00 – 15:30 Legal and Regulatory Issues
EU Legislation on Tissues and Cells – State of Play
Stefaan Van der Spiegel (Brussels, Belgium)
Data Protection out of Control
Security and Privacy in the New Digital World
Frank Kargl (Ulm, Germany)
16:00 – 17:00 Shirley Nolan Lecture
Day 5: Saturday – June 30, 2018
09:00 – 10:30 Current Hot Topics
What Do You Expect from a Registry? Minimum Criteria for Our Partners
Dena Mercer (Ottawa, Canada)
Hot Topics
Selected Abstract Presentations
11:00 – 12:30 Towards Integration and Standardization
Ethnicity Concepts for Hematopoietic Stem Cell Donors
Jill Hollenbach (San Francisco, United States)
Should We Move Towards Full Gene Sequencing
1. Yes
Neema Mayor (London, United Kingdom)
2. No
Carolyn Hurley (Rockville, United States)
Strategical Considerations in a Rapidly Changing World
Carlheinz Müller (Ulm, Germany)
14:00 – 16:00 Research of Today – Routine of Tomorrow
Cordblood – Quo Vadis 2025
Jaap Jan Boelens (Utrecht, Netherlands)
Practical Opportunities Arising from the Extended Donor Profile
Alexander Schmidt (Tübingen, Germany)
Ethical and Legal Aspects of Whole Genome Sequencing in Diagnostics and Research

Please note, that the preliminary program is subject to change.